Moderna cancer vaccine results confirm efficacy; AI's lifecycle in drug development
anshulkundaje · x · 2026-08-20
Moderna and Merck's cancer vaccine confirmed Phase 2 results in a late-stage melanoma trial. The author discusses the lifecycle of AI in drug development, distinguishing between 'boring' legacy ML techniques embedded in diagnostics and the 'hypey' frontier areas like virtual cells.
More from Companies & People
- Dario Amodei says AI better than humans at almost everything may be 2-3 years away — PolarBearby · 2026-10-16
- Jensen Huang: Musk's AI buildout moved from K's to M's, now a CSP-tier NVIDIA customer — elonmusk · 2026-10-16
- Vercel CEO Rauch and Shopify CEO Tobi Lütke share stage at Ship SF — evilrabbit_ · 2026-10-16
- Australia's AERO guidance: avoid AI entirely in first three years of primary school — lmoroney · 2026-10-16
- Alexandr Wang: Meta Superintelligence Labs is in South Bay, and strangers talking to you means something's up — HanchungLee · 2026-10-16
- Accenture caps Claude reimbursement at $29/month while employees spend up to $1,000 — inductionheads · 2026-10-16